Blog

Amy C. Moore: LUNGevity Foundation International Lung Cancer Survivorship Conference

Photo taken from Amy C. Moore/LinkedIn

Jun 13, 2024, 10:46

Amy C. Moore: LUNGevity Foundation International Lung Cancer Survivorship Conference

Amy C. Moore, VP of Global Engagement and Patient Partnerships, LUNGevity Foundation, shared a post on LinkedIn:

“It has been 20 years since the discovery of the EGFR mutation ushered in the era of precision medicine for lung cancer. We are celebrating this important milestone and many more research advances at this year’s LUNGevity Foundation International Lung Cancer Survivorship Conference (ILCSC24), happening virtually Sept 20 – 21. Sign up to get notified when registration opens”

Read further.
Source: Amy C. Moore/LinkedIn

Amy C. Moore cancer EGFR-mutation ILCSC24 International Lung Cancer Survivorship Conference lung cancer research LUNGevity Foundation OncoDaily Oncology Precision Medicine registration notification research advances survivorship virtual conference

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage